Journal
ACS CHEMICAL BIOLOGY
Volume 10, Issue 8, Pages 1831-1837Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acschembio.5b00442
Keywords
-
Categories
Funding
- Department of Defense [W81XWH-12-1-0484]
- National Institutes of Health [RO1AI084140, F32GM10052101, T32GM067543]
Ask authors/readers for more resources
Small molecule-induced protein degradation is an attractive strategy for the development of chemical probes. One method for inducing targeted protein degradation involves the use of PROTACs, heterobifunctional molecules that can recruit specific E3 ligases to a desired protein of interest. PROTACs have been successfully used to degrade numerous proteins in cells, but the peptidic E3 ligase ligands used in previous PROTACs have hindered their development into more mature chemical probes or therapeutics. We report the design of a novel class of PROTACs that incorporate small molecule VHL ligands to successfully degrade HaloTag7 fusion proteins. These HaloPROTACs will inspire the development of future PROTACs with more drug-like properties. Additionally, these HaloPROTACs are useful chemical genetic tools, due to their ability to chemically knock down widely used HaloTag7 fusion proteins in a general fashion.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available